Superworth

PAVmed EPS PAVM

Diluted earnings per share by quarter and over the last twelve months, from 2015.

Last 12 months, to Jun 30, 2026
−$16.04
Latest quarter, Q2 FY26
−$0.87
Fiscal year 2025
−$22.73

PAVmed's earnings per share was −$16.04 over the twelve months to Jun 30, 2026, down 151% on a year earlier.

In its latest quarter, Q2 FY26, it was −$0.87.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$22.73n/a
FY2024−$70.79n/a
FY2023−$277.20n/a
FY2022n/an/a
FY2021−$301.50n/a
FY2020−$328.50n/a
FY2019−$247.50n/a
FY2018−$364.50n/a
FY2017−$342.00n/a
FY2016−$193.50n/a
FY2015−$67.50n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.87n/a−$16.04
Q1 FY26−$4.42−144%−$37.25
Q4 FY25−$2.05−761%−$22.73
Q3 FY25−$8.70−120%−$20.37
Q2 FY25−$22.08n/a$31.53
Q1 FY25$10.10n/a$17.91
Q4 FY24$0.31n/a−$70.79
Q3 FY24$43.20n/a−$130.50
Q2 FY24−$35.70n/a−$245.10
Q1 FY24−$78.60n/a−$272.40
Q4 FY23−$59.40n/a−$277.20
Q3 FY23−$71.40n/a−$317.10

Against its peers

Companies in Medical - Instruments & Supplies nearest PAVmed's size, closest first, today.

CompanyEPS, 12 monthsGrowth
PAVMPAVmed−$16.04−151% a year
NEPHNephros$0.16+33% a year
APTAlpha Pro Tech$0.41+24% a year
KEQUKewaunee Scientific$2.76−33% a year
Peer median$0.41

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on PAVmed

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.